Does delayed EBV infection contribute to rising childhood cancers?

Steliarova-Foucher, 2018, Changing geographical patterns and trends in cancer incidence in children and adolescents in Europe, 1991-2010 (Automated Childhood Cancer Information System): a population-based study, Lancet Oncol., 19, 1159, 10.1016/S1470-2045(18)30423-6 Gilham, 2005, Day care in infancy and risk of childhood acute lymphoblastic leukaemia: findings from UK case-control study, BMJ, 330, 1294, 10.1136/bmj.38428.521042.8F Greaves, 2018, A causal mechanism for childhood acute lymphoblastic leukaemia, Nat. Rev. Cancer, 18, 471, 10.1038/s41568-018-0015-6 Hawkes, 2018, Childhood leukaemia may be preventable by exposure to infections in early life, BMJ, 361 Cobaleda, 2021, An immune window of opportunity to prevent childhood B cell leukemia, Trends Immunol., 42, 371, 10.1016/j.it.2021.03.004 Hauer, 2021, Toward prevention of childhood ALL by early-life immune training, Blood, 138, 1412, 10.1182/blood.2020009895 Swaminathan, 2015, Mechanisms of clonal evolution in childhood acute lymphoblastic leukemia, Nat. Immunol., 16, 766, 10.1038/ni.3160 Choi, 2021, Mechanism of EBV inducing anti-tumour immunity and its therapeutic use, Nature, 590, 157, 10.1038/s41586-020-03075-w Long, 2009, CD4+ T-cell clones recognizing human lymphoma-associated antigens: generation by in vitro stimulation with autologous Epstein-Barr virus-transformed B cells, Blood, 114, 807, 10.1182/blood-2008-12-194043 Zhang, 2022, Facts and hopes in the relationship of EBV with cancer immunity and immunotherapy, Clin. Cancer Res. Bollard, 2014, Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins, J. Clin. Oncol., 32, 798, 10.1200/JCO.2013.51.5304 Hjalgrim, 2007, The epidemiology of EBV and its association with malignant disease, 929 Balfour, 2013, Age-specific prevalence of Epstein-Barr virus infection among individuals aged 6-19 years in the United States and factors affecting its acquisition, J. Infect. Dis., 208, 1286, 10.1093/infdis/jit321 Ehlers, 2010, Lymphocryptovirus phylogeny and the origins of Epstein-Barr virus, J. Gen. Virol., 91, 630, 10.1099/vir.0.017251-0 Cohen, 2011, Epstein-Barr virus: an important vaccine target for cancer prevention, Sci. Transl. Med., 3, 10.1126/scitranslmed.3002878 Cohen, 2015, Epstein-Barr virus vaccines, Clin. Transl. Immunol., 4, 10.1038/cti.2014.27